Removal ability of IgG anti-GQ1b antibody in immunoadsorption therapy for Fisher syndrome -Comparison of the removal ability between tryptophane column and phenylalanine column

Clinical Neurology

Volumn 36, Issue 2, 1996, Pages 323-329

  Ichikawa, Hiroo ^a   Suzuki, Mamoru ^a   Kawamura, Mitsuru ^a   Sugita, Koujiro ^a   Watanabe, Yasuki ^c   Yuki, Nobuhiro ^b  

^a SHOWA UNIVERSITY   (Japan)

^b Department of Neurology

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Anti GQ1b antibodies; Fisher syndrome; Immunoadsorption therapy; Phenylalanine column; Tryptophane column

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOADSORPTION; INTERMETHOD COMPARISON; SUBCLAVIAN STEAL SYNDROME; TREATMENT OUTCOME;

ADULT; AUTOANTIBODIES; CEREBELLAR ATAXIA; FEMALE; GANGLIOSIDES; HUMANS; IMMUNOGLOBULIN G; IMMUNOSORBENT TECHNIQUES; OPHTHALMOPLEGIA; PHENYLALANINE; POLYRADICULONEUROPATHY; REFLEX, ABNORMAL; SYNDROME; TRYPTOPHAN;

EID: 0029890151     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol 36 : 791-793, 1994
2. 1b is a possible marker of Miller Fisher syndrome. Ann Neurol 31 : 677-679, 1992
3. 1b antibody in Fisher's syndrome. Neurology 43 : 414-417, 1993
4. Yuki N, Miyatake T, Ohsawa T : Beneficial effect of plasmapheresis on Fisher's syndrome. Muscle Nerve 16 : 1267-1268, 1993
5. Roberts M, Willison H, Vincent A, et al : Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet 343 : 454-455, 1994
6. The Guillain-Barré syndrome study group : Plasmapheresis and acute Guillain-Barré syndrome. Neurology 35 : 1096-1104, 1985
7. French cooperative group on plasma exchange in Guillain-Barré syndrome : Efficiency of plasma exchange in Guillain-Barré syndrome : role of replacement fluids. Ann Neurol 22 : 753-761, 1987
8. McKhann GM, Griffin JW, Cornblath DR, et al : Plasmapheresis and Guillain-Barré syndrome : analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol 23 : 347-353, 1988
9. Hughes RAC, Newsom-Davis JM, Perkin GD, et al : Controlled trial of prednisolone in acute polyneuropathy. Lancet II : 750-753, 1978
10. Guillain-Barré syndrome steroid trial group : Doubleblind trial of intravenous methylprednisolone in Guillain-Barré syndrome. Lancet 341 : 586-590, 1993
11. Littlewood R, Bajada S : Successful plasmapheresis in the Miller-Fisher syndrome. Br Med J 282 : 778, 1981
12. Irvine AT, Tibbles J : Treatment of Fisher's variant of Guillain-Barré syndrome by exchange transfusion. Can J Neurol Sci 8 : 49-50, 1981
13. Wrobel CJ, Watson D : Plasmapheresis in chronic demyelinating polyneuropathy. N Engl J Med 326 : 1089-1090, 1992
14. Koh C-S, Shinoda T, Shimada K, et al : Immunoadsorption plasmapheresis and plasma exchange in Miller Fisher syndrome. In Therapeutic plasmapheresis (XII), ed by Agishi T, Kawamura A, Mineshima M, VSP International Science Publishers, Utrecht, 1993, pp557-560
15. Shimizu H, Ishikawa K, Hirabayashi K, et al : Plasma immunoadsorption therapy in Fisher's syndrome. In Therapeutic plasmapheresis (XII), ed by Agishi T, Kawamura A, Mineshima M, VSP International Science Publishers, Utrecht, 1993, pp581-583
16. Grob D, Simpson D, Mitsumoto H, et al : Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45 : 338-344, 1995
17. Flaum MA, Cuneo RA, Appelbaum FR, et al : The hemostatic imbalance of plasma-exchange transfusion. Blood 54 : 694 702, 1979